NeueHealth, Inc.

Symbol: NEUE

NYSE

6.0501

USD

Market price today

  • -0.0418

    P/E Ratio

  • 0.0001

    PEG Ratio

  • 48.73M

    MRK Cap

  • 0.00%

    DIV Yield

NeueHealth, Inc. (NEUE) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.12%

Operating Profit Margin

-0.38%

Net Profit Margin

-0.71%

Return on Assets

-0.94%

Return on Equity

-7.82%

Return on Capital Employed

3.73%

Company general description and statistics

Sector: Healthcare
Industry: Healthcare
CEO:Mr. George Lawrence Mikan III
Full-time employees:1252
City:Doral
Address:9250 NW 36th St
IPO:2021-06-24
CIK:0001671284

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

General Outlook

When we look at how much money they make before expenses, they keep 0.119% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.382%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.712%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.940% return, is a testament to NeueHealth, Inc.'s adeptness in optimizing resource deployment. NeueHealth, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -7.820%. Furthermore, the proficiency of NeueHealth, Inc. in capital utilization is underscored by a remarkable 3.727% return on capital employed.

Stock Prices

NeueHealth, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.3, while its low point bottomed out at $6.05. This variance in figures offers investors a lucid insight into the roller-coaster ride that is NeueHealth, Inc.'s stock market.

Liquidity Ratios

Analyzing NEUE liquidity ratios reveals its financial health of the firm. The current ratio of 78.27% gauges short-term asset coverage for liabilities. The quick ratio (17.86%) assesses immediate liquidity, while the cash ratio (6.27%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio78.27%
Quick Ratio17.86%
Cash Ratio6.27%

Profitability Ratios

NEUE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -41.45% underscores its earnings before tax deductions. The effective tax rate stands at 0.21%, revealing its tax efficiency. The net income per EBT, 171.85%, and the EBT per EBIT, 108.44%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -38.22%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-41.45%
Effective Tax Rate0.21%
Net Income per EBT171.85%
EBT per EBIT108.44%
EBIT per Revenue-38.22%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.78, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding18
Days of Inventory Outstanding211
Operating Cycle245.68
Days of Payables Outstanding3
Cash Conversion Cycle243
Receivables Turnover10.43
Payables Turnover120.34
Inventory Turnover1.73
Fixed Asset Turnover111.50
Asset Turnover1.32

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -342.79, and free cash flow per share, -343.15, depict cash generation on a per-share basis. The cash per share value, 11.76, showcases liquidity position. Lastly, the operating cash flow sales ratio, -1.69, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-342.79
Free Cash Flow per Share-343.15
Cash per Share11.76
Operating Cash Flow Sales Ratio-1.69
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-7.36
Short Term Coverage Ratio-8.97
Capital Expenditure Coverage Ratio-941.16
Dividend Paid and Capex Coverage Ratio-941.16

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 30.22%, highlights its total liabilities relative to assets. With a debt-equity ratio of -1.08, we discern the balance between debt and equity financing. The long-term debt to capitalization, -23.96%, and total debt to capitalization, 1380.81%, ratios shed light on its capital structure. An interest coverage of -16.17 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio30.22%
Debt Equity Ratio-1.08
Long Term Debt to Capitalization-23.96%
Total Debt to Capitalization1380.81%
Interest Coverage-16.17
Cash Flow to Debt Ratio-7.36
Company Equity Multiplier-3.57

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 145.94, provides a glimpse into top-line earnings distributed across each share. Net income per share, -144.76, reflects the portion of profit attributed to each share. The book value per share, -43.19, represents the net asset value distributed per share, while the tangible book value per share, -43.73, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share145.94
Net Income Per Share-144.76
Book Value Per Share-43.19
Tangible Book Value Per Share-43.73
Shareholders Equity Per Share-43.19
Interest Debt Per Share51.36
Capex Per Share-0.36

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 54.53%, indicates top-line expansion, while the gross profit growth, 86.21%, reveals profitability trends. EBIT growth, -56.47%, and operating income growth, -56.47%, offer insights into operational profitability progression. The net income growth, 20.89%, showcases bottom-line expansion, and the EPS growth, 21.75%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth54.53%
Gross Profit Growth86.21%
EBIT Growth-56.47%
Operating Income Growth-56.47%
Net Income Growth20.89%
EPS Growth21.75%
EPS Diluted Growth21.75%
Weighted Average Shares Growth1.09%
Weighted Average Shares Diluted Growth1.09%
Operating Cash Flow Growth-1262.87%
Free Cash Flow Growth-1418.46%
10-Year Revenue Growth per Share306.67%
5-Year Revenue Growth per Share306.67%
3-Year Revenue Growth per Share118.03%
10-Year Operating CF Growth per Share-32563.30%
5-Year Operating CF Growth per Share-32563.30%
3-Year Operating CF Growth per Share-4506.69%
10-Year Net Income Growth per Share-803.34%
5-Year Net Income Growth per Share-803.34%
3-Year Net Income Growth per Share-348.21%
10-Year Shareholders Equity Growth per Share-155.50%
5-Year Shareholders Equity Growth per Share-155.50%
3-Year Shareholders Equity Growth per Share34.04%
Receivables Growth30.49%
Inventory Growth-74.19%
Asset Growth-73.73%
Book Value per Share Growth-147.20%
Debt Growth21.85%
SGA Expenses Growth-17.76%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 348,668,500, captures the company's total value, considering both debt and equity. Income quality, 2.15, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 7.61%, indicates the value of non-physical assets, and capex to operating cash flow, 0.11%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value348,668,500
Income Quality2.15
Sales General and Administrative to Revenue0.22
Intangibles to Total Assets7.61%
Capex to Operating Cash Flow0.11%
Capex to Revenue-0.25%
Capex to Depreciation-11.99%
Stock-Based Compensation to Revenue7.21%
Graham Number375.07
Return on Tangible Assets-101.70%
Graham Net Net-108.00
Working Capital-302,330,000
Tangible Asset Value-347,856,000
Net Current Asset Value-391,171,000
Invested Capital-1
Average Receivables136,859,500
Average Payables15,277,500
Average Inventory2,005,017,000
Days Sales Outstanding49
Days Payables Outstanding4
Days of Inventory On Hand301
ROIC-2146.40%
ROE3.35%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.14, and the price to book ratio, -0.14, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.03, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.02, and price to operating cash flows, -0.02, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-0.14
Price to Book Ratio-0.14
Price to Sales Ratio0.03
Price Cash Flow Ratio-0.02
Enterprise Value Multiple1.29
Price Fair Value-0.14
Price to Operating Cash Flow Ratio-0.02
Price to Free Cash Flows Ratio-0.02
Price to Tangible Book Ratio-0.19
Enterprise Value to Sales0.30
Enterprise Value Over EBITDA-2.41
EV to Operating Cash Flow-0.13
Earnings Yield-1754.72%
Free Cash Flow Yield-4159.44%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of NeueHealth, Inc. (NEUE) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.042 in 2024.

What is the ticker symbol of NeueHealth, Inc. stock?

The ticker symbol of NeueHealth, Inc. stock is NEUE.

What is company IPO date?

IPO date of NeueHealth, Inc. is 2021-06-24.

What is company current share price?

Current share price is 6.050 USD.

What is stock market cap today?

The market cap of stock today is 48728225.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1252.